Guggenheim Capital LLC Purchases 4,933 Shares of Chimera Investment Co. (NYSE:CIM)

Guggenheim Capital LLC lifted its position in shares of Chimera Investment Co. (NYSE:CIM – Get Rating) by 4.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 123,090 shares of the real estate investment trust’s stock after acquiring an additional 4,933 shares during the period. Guggenheim Capital LLC owned approximately 0.05% of Chimera Investment worth $642,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Ergoteles LLC purchased a new position in shares of Chimera Investment during the 3rd quarter worth $162,000. Equitable Holdings Inc. bought a new stake in shares of Chimera Investment in the 3rd quarter worth about $131,000. MML Investors Services LLC grew its holdings in Chimera Investment by 10.7% during the 3rd quarter. MML Investors Services LLC now owns 27,016 shares of the real estate investment trust’s stock valued at $141,000 after purchasing an additional 2,617 shares during the last quarter. MetLife Investment Management LLC grew its holdings in Chimera Investment by 3.5% during the 3rd quarter. MetLife Investment Management LLC now owns 125,178 shares of the real estate investment trust’s stock valued at $653,000 after purchasing an additional 4,212 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Chimera Investment by 1.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 350,607 shares of the real estate investment trust’s stock valued at $1,830,000 after buying an additional 4,829 shares during the period. Institutional investors own 47.06% of the company’s stock.

Chimera Investment Price Performance

Shares of CIM opened at $5.66 on Friday. The company has a debt-to-equity ratio of 2.69, a current ratio of 0.09 and a quick ratio of 0.09. The stock has a market cap of $1.31 billion, a PE ratio of -2.27 and a beta of 1.51. The firm has a 50-day simple moving average of $6.67 and a two-hundred day simple moving average of $6.70. Chimera Investment Co. has a 1-year low of $4.91 and a 1-year high of $12.73.

Chimera Investment (NYSE:CIM – Get Rating) last issued its quarterly earnings data on Wednesday, February 15th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.24 by ($0.13). Chimera Investment had a positive return on equity of 11.35% and a negative net margin of 66.36%. The company had revenue of $187.29 million for the quarter, compared to analysts’ expectations of $97.90 million. During the same quarter in the prior year, the firm posted $0.46 EPS. As a group, analysts forecast that Chimera Investment Co. will post 0.78 EPS for the current year.

Chimera Investment Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 27th. Stockholders of record on Friday, March 31st will be paid a dividend of $0.23 per share. The ex-dividend date is Thursday, March 30th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 16.25%. Chimera Investment’s dividend payout ratio (DPR) is presently -36.95%.

Wall Street Analysts Forecast Growth

CIM has been the subject of several research reports. Royal Bank of Canada reissued an “outperform” rating and issued a $7.00 price objective on shares of Chimera Investment in a research report on Tuesday. Credit Suisse Group restated a “neutral” rating and set a $6.50 price target on shares of Chimera Investment in a research note on Thursday. One analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $7.50.

About Chimera Investment

(Get Rating)

Chimera Investment Corp. is a real estate investment trust, which engages in the business of investing in a portfolio of mortgage assets, including residential mortgage loans, Agency RMBS, Non-Agency RMBS, Agency CMBS, and other real estate-related assets. The company was founded on June 1, 2007 and is headquartered in New York, NY.